Creo Medical Group PLC Change of Nominated Adviser and Joint Broker (2396Q)
16 Ottobre 2023 - 11:16AM
UK Regulatory
TIDMCREO
RNS Number : 2396Q
Creo Medical Group PLC
16 October 2023
Creo Medical Group plc
("Creo" the "Company" or the "Group")
Change of Nominated Adviser and Joint Broker
Creo Medical Group plc (AIM: CREO), a medical device company
focused on the emerging field of surgical endoscopy, announces that
following the completion of the all share merger between Cavendish
Securities plc (previously named Cenkos Securities plc) and
Cavendish Financial plc (previously named finnCap Group plc), as a
consequence of internal reorganisation within the Cavendish Group,
the Company has changed its Nominated Adviser and Joint Broker from
Cavendish Securities plc to Cavendish Capital Markets Limited.
Enquiries:
Creo Medical Group plc www.creomedical.com
Richard Rees (CFO) +44 (0)1291 606 005
Cavendish Capital Markets Limited +44 (0)20 7397 8900
Stephen Keys / Camilla Hume (NOMAD)
Michael Johnson (Sales)
Numis Securities Limited (Joint
Broker) +44 (0)20 7260 1000
Freddie Barnfield / Duncan Monteith
/ Euan Brown
Walbrook PR Ltd Tel: + 44 ( 0)20 7933 8780 or creo@walbrookpr.com
Paul McManus / Sam Allen Mob: +44 (0)7980 541 893 / +44 (0)7502
Phillip Marriage 558 258
+44 (0)7867 984 082
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPFFLSUMEDSEFS
(END) Dow Jones Newswires
October 16, 2023 05:16 ET (09:16 GMT)
Grafico Azioni Creo Medical (LSE:CREO)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Creo Medical (LSE:CREO)
Storico
Da Set 2023 a Set 2024